skip to main content

Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management - a follow-up study in a private inflammatory bowel disease center (2003-2017)

Cury, D B ; Oliveira, R ; Cury, M S

Journal of inflammation research, 2019-05, Vol.12, p.127-135 [Periódico revisado por pares]

New Zealand: Dove Medical Press Limited

Texto completo disponível

Citações Citado por
  • Título:
    Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management - a follow-up study in a private inflammatory bowel disease center (2003-2017)
  • Autor: Cury, D B ; Oliveira, R ; Cury, M S
  • Assuntos: anti-TNF ; Colitis ; Development and progression ; Diarrhea ; Diseases ; Epidemiology ; extraintestinal manifestations ; inflammatory bowel disease ; Inflammatory bowel diseases ; main symptoms ; Medical research ; Medicine, Experimental ; Original Research ; Time ; Ulcerative colitis
  • É parte de: Journal of inflammation research, 2019-05, Vol.12, p.127-135
  • Descrição: The governmental program of Brazilian Unified National Health System has already published studies on the incidence of inflammatory bowel diseases (IBD), but up until now, there have been no epidemiological studies in private centers in Brazil. However, these diseases tend to affect people from a higher socioeconomic class, mainly in the capital of MS state that has the third highest GDP in Brazil. The aim was to analyze an observational, descriptive study of an IBD database in a private center including: the side, behavior of the disease and medical management, the association of extra-intestinal manifestations, and the main clinical symptoms which led to the investigation and diagnosis of IBD. A cohort study was developed in which data of all patients with IBD were analyzed with SPSS software in a constructed electronic database. Of 329 patients, 212 (64.4%) had Crohn's disease (CD) and 117 (35.6%) had ulcerative colitis (UC). Average age at diagnosis of CD was 36.19 (±14.33) and of UC was 41.61 (±15.37). An amount of 50.05% of the patients with CD and 72.7% ( <0.001) with UC were female. We have observed that concerning the first symptoms, diahrrea and blood feces corresponded to 70% in UC while in CD 50% of the patients presented diahrrea with blood feces, loss of weight corresponded to 50% and only diahrrea 25%. ( <0.001). Anti-TNFs corresponded to 56.2% being more frequent in CD 0.001%. CD patients used biologic therapy and antibiotics more frequently than those with UC. In conclusion, IBD is also frequent in private health care centers in Brazil; women are most affected. Symptoms such as diarrhea and bleeding, as well as diarrhea and weight loss, must be taken as warning signs to investigate for inflammatory disease. The use of biologic therapies is frequent in referral centers when patients have severe disease.
  • Editor: New Zealand: Dove Medical Press Limited
  • Idioma: Inglês

Buscando em bases de dados remotas. Favor aguardar.